GMP Violation

GMP Violation by Alembic Pharma

Violation of good manufacturing practices by sterile injectables unit of Alembic Pharma identified by USFDA At the beginning of February 2021, the US drug regulator issued “Form 483” to the Kharkhadi unit of Alembic Pharma. This is a sterile injectables manufacturing unit of the drug firm that is situated in Gujarat. The form was issued …

GMP Violation by Alembic Pharma Read More »